Rocket One Inc. Costs and Expenses
Rocket One Inc. (RKTO) reported Costs and Expenses of $29.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2024-03-28
- Rocket One Inc. costs and expenses for the quarter ending 2023-12-31 was -$1.00K, a 110.00% decline year-over-year.
- Rocket One Inc. costs and expenses for the quarter ending 2023-09-30 was $30.00K, a 150.00% increase year-over-year.
- Rocket One Inc. costs and expenses for the quarter ending 2023-06-30 was $30.00K, a 100.00% increase year-over-year.
- Rocket One Inc. costs and expenses for the quarter ending 2023-03-31 was $30.00K.
- Rocket One Inc. costs and expenses for fiscal 2023 was $29.00K, a 45.28% decline from fiscal 2022.
- Rocket One Inc. costs and expenses for fiscal 2022 was $53.00K.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $29.00K derived: sum of 2 quarters · filed 2024-03-28 | $59.00K derived: sum of 3 quarters · filed 2024-03-28 | $29.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $30.00K 10-Q · filed 2023-11-13 | $60.00K derived: sum of 2 quarters · filed 2023-11-13 | $30.00K 10-Q · filed 2023-11-13 | $100.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $30.00K 10-Q · filed 2023-08-11 | $30.00K 10-Q · filed 2023-08-11 | $70.00K derived: sum of 3 quarters · filed 2024-03-28 | $82.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $30.00K 10-Q · filed 2023-05-15 | $40.00K derived: sum of 2 quarters · filed 2024-03-28 | $52.00K derived: sum of 3 quarters · filed 2024-03-28 | $67.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $22.00K derived: sum of 2 quarters · filed 2024-03-28 | $37.00K derived: sum of 3 quarters · filed 2024-03-28 | $53.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $12.00K 10-Q · filed 2022-11-10 | $27.00K derived: sum of 2 quarters · filed 2022-11-10 | $43.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $15.00K 10-Q · filed 2022-08-12 | $31.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |